P1.16-04 Phase 3 EVOKE-01 Study of Sacituzumab Govitecan vs Docetaxel in NSCLC After Prior Platinum and Checkpoint Inhibitors

20222 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Thoracic Oncology

Volume 17, Issue 9, pp. S128-S128

Field-Weighted Citation Impact: 0.29